CCND2 and cancer: It remains unclear why the loss of CCND2, and, therefore, CCND2-associated cell proliferation, is observed in cancers, but this may be due to a compensation effect leading to the up-regulation of another cyclin, e.g., cyclin E. Another explanation may be related to the stage or sub-type of cancer.